Therapeutic evaluation of a first-generation L. amazonensis antigen vaccine with TLR-3 ligand adjuvant.
Leishmaniasis is an expanding parasitic zoonosis in South America and is considered one of the neglected diseases by the WHO because it primarily affects low-income populations with limited access to healthcare services. Currently, there is no vaccine available for the prevention of human leishmaniasis, and existing tr...